GIANI, TOMMASO
 Distribuzione geografica
Continente #
NA - Nord America 7.399
EU - Europa 6.144
AS - Asia 3.868
SA - Sud America 718
AF - Africa 115
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.301
Nazione #
US - Stati Uniti d'America 7.296
PL - Polonia 1.993
RU - Federazione Russa 1.725
IT - Italia 1.062
SG - Singapore 1.059
CN - Cina 991
BR - Brasile 584
HK - Hong Kong 543
VN - Vietnam 492
IE - Irlanda 348
KR - Corea 315
SE - Svezia 235
DE - Germania 159
FR - Francia 136
IN - India 127
FI - Finlandia 118
NL - Olanda 108
GB - Regno Unito 100
ID - Indonesia 70
CA - Canada 60
AU - Australia 50
AR - Argentina 48
BD - Bangladesh 46
JO - Giordania 46
ES - Italia 37
IQ - Iraq 30
UA - Ucraina 26
ZA - Sudafrica 25
EC - Ecuador 23
JP - Giappone 23
PK - Pakistan 22
BE - Belgio 20
CO - Colombia 20
MX - Messico 20
TR - Turchia 18
PY - Paraguay 14
CH - Svizzera 13
MA - Marocco 13
NG - Nigeria 13
UZ - Uzbekistan 13
CI - Costa d'Avorio 12
EG - Egitto 12
LT - Lituania 11
SA - Arabia Saudita 11
KE - Kenya 10
TN - Tunisia 9
VE - Venezuela 9
KZ - Kazakistan 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
CL - Cile 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
BJ - Benin 5
BO - Bolivia 5
GR - Grecia 5
JM - Giamaica 5
PT - Portogallo 5
RO - Romania 5
UY - Uruguay 5
BG - Bulgaria 4
IL - Israele 4
PE - Perù 4
QA - Qatar 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
EE - Estonia 3
EU - Europa 3
LU - Lussemburgo 3
MY - Malesia 3
NP - Nepal 3
OM - Oman 3
TH - Thailandia 3
AM - Armenia 2
AT - Austria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MD - Moldavia 2
MM - Myanmar 2
MU - Mauritius 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
CG - Congo 1
CM - Camerun 1
GH - Ghana 1
IS - Islanda 1
Totale 18.288
Città #
Warsaw 1.990
Santa Clara 1.606
Ashburn 807
Singapore 780
Fairfield 743
Hong Kong 464
Dublin 348
Woodbridge 338
Seattle 315
Seoul 311
Chandler 291
Houston 283
Cambridge 259
Wilmington 257
Beijing 222
Hefei 201
San Jose 166
Ho Chi Minh City 162
Ann Arbor 152
Altamura 141
Florence 138
Princeton 129
Lawrence 110
Hanoi 102
Lauterbourg 92
Los Angeles 92
Moscow 89
The Dalles 89
Munich 73
Boston 69
Buffalo 64
Clifton 64
Mumbai 64
Council Bluffs 54
Rome 53
New York 51
Jakarta 50
Shanghai 50
Melbourne 44
Helsinki 43
São Paulo 42
Medford 39
Milan 38
San Diego 37
Dong Ket 36
Frankfurt am Main 32
Salerno 32
Austin 31
Dallas 29
Barcelona 23
Kent 23
Phoenix 23
London 21
Falls Church 20
Rio de Janeiro 20
Siena 20
Redondo Beach 19
Tokyo 19
Brussels 18
Da Nang 18
Guangzhou 18
Boardman 17
Chicago 17
Haiphong 17
Turin 16
Lappeenranta 15
Norwalk 15
Bengaluru 14
Brooklyn 14
Hillsboro 14
Orem 14
West Jordan 14
Amsterdam 13
Naples 13
Tianjin 13
Abidjan 12
Baghdad 12
Chennai 12
Hải Dương 12
Montreal 12
Porto Alegre 12
Shenzhen 12
Abuja 11
Belo Horizonte 11
Biên Hòa 11
Johannesburg 11
Tashkent 11
Toronto 11
Turku 11
Atlanta 10
Bari 10
Paris 10
Quito 10
Yubileyny 10
Andover 9
Asunción 9
Campinas 9
Denver 9
Dhaka 9
Düsseldorf 9
Totale 12.385
Nome #
Evaluation of VITEK® 2 AST cards (AST-N376 and AST-N397) for susceptibility testing of challenging Gram negatives 613
Citrobacter braakii carrying plasmid-borne mcr-1 colistin resistance gene from ready-to-eat food from a market in the Chaco region of Bolivia 341
A new selective broth enrichment automated method for detection of carbapenem-resistant Enterobacteriaceae from rectal swabs 308
A simple phenotypic method for screening of MCR-1-mediated colistin resistance 299
Molecular antibiogram in diagnostic clinical microbiology: advantages and challenges 297
Breakthrough bacteremia by linezolid-susceptible Enterococcus faecalis under linezolid treatment in a severe polytrauma patient. 296
Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: Increasing diversity with predominance of the ST512 clade II sublineage 280
Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014 277
Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients 275
Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011 254
Diversity of capsular polysaccharide gene clusters in Kpc-producing Klebsiella pneumoniae clinical isolates of sequence type 258 involved in the italian epidemic 254
Mother-to-child transmission of KPC carbapenemase-producing Klebsiella pneumoniae at birth 249
Infections caused by carbapenem-resistant Klebsiella pneumoniae with hypermucoviscous phenotype: A case report and literature review 244
An allelic variant of the PmrB sensor kinase responsible for colistin resistance in an Escherichia coli strain of clinical origin /631/326/22/1434 /631/326/325/1506 /631/337/458/1733 /38 /64 /45 /45/70 /45/44 /45/23 article 237
Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers 236
Plasmid-mediated or chromosomally mediated colistin resistance in Klebsiella pneumoniae? 228
Methicillin-resistant Staphylococcus aureus in hospitalized patients from the Bolivian Chaco. 223
CXC chemokines exhibit bactericidal activity against multidrug-resistant gram-negative pathogens 222
First report of NDM-1-producing Klebsiella pneumoniae imported from Africa to Italy: Evidence of the need for continuous surveillance 221
Mother-to-child transmission of KPC-producing Klebsiella pneumoniae: Potential relevance of a low microbial urinary load for screening purposes 215
Characterization of KPC-encoding plasmids from two endemic settings, Greece and Italy 195
Complete genome sequence of the first KPC-type carbapenemase-positive Proteus mirabilis strain from a bloodstream infection 194
Accuracy of different methods for susceptibility testing of gentamicin with KPC carbapenemase-producing Klebsiella pneumoniae 193
Nosocomial outbreak by NDM-1-producing Klebsiella pneumoniae highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022 191
High prevalence of carriage of mcr-1-positive enteric bacteria among healthy children from rural communities in the Chaco region, Bolivia, september to october 2016 190
Multicenter evaluation of the RAPIDEC® CARBA NP test for rapid screening of carbapenemase-producing Enterobacteriaceae and Gram-negative nonfermenters from clinical specimens 189
Emergence in Italy of Klebsiella pneumoniae sequence type 258 producing KPC-3 Carbapenemase. 187
Epidemic diffusion of OXA-23-producing acinetobacter baumannii isolates in Italy: Results of the first cross-sectional countrywide survey 182
mcr-1 gene expression modulates the inflammatory response of human macrophages to Escherichia coli 182
Draft genome sequence of the first hypermucoviscous Klebsiella quasipneumoniae subsp. quasipneumoniae isolate from a bloodstream infection 181
Colistin resistance caused by inactivation of the MgrB regulator is not associated with decreased virulence of sequence type 258 KPC carbapenemase-producing Klebsiella pneumoniae 180
Recurrent emergence of Klebsiella pneumoniae carbapenem resistance mediated by an inhibitory ompK36 mRNA secondary structure 177
Bactericidal activity of ceftaroline against mature Staphylococcus aureus biofilms 177
Characterization of pFOX-7a, a conjugative IncL/M plasmid encoding the FOX-7 AmpC-type β-lactamase, involved in a large outbreak in a neonatal intensive care unit 176
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience 174
Diversity of the epidemiology of carbapenemase-producing Enterobacteriaceae in long-term acute care rehabilitation settings from an area of hyperendemicity, and evaluation of an intervention bundle 174
Inappropriate use of carbapenems in an internal medicine ward: Impact of a carbapenem-focused antimicrobial stewardship program 171
Performance of the BD MAX™ instrument with Check-Direct CPE real-time PCR for the detection of carbapenemase genes from rectal swabs, in a setting with endemic dissemination of carbapenemase-producing Enterobacteriaceae 170
Catheter-related bacteremia by Cupriavidus metallidurans 169
Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy 169
mcr-1.2, a new mcr variant carried on a transferable plasmid from a colistin-resistant KPC carbapenemase-producing Klebsiella pneumoniae strain of sequence type 512 167
Large nosocomial outbreak of colistin-resistant, carbapenemase-producing klebsiella pneumoniae traced to clonal expansion of an mgrb deletion mutant 167
MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin 165
Resistome and virulome accretion in an NDM-1-producing ST147 sublineage of Klebsiella pneumoniae associated with an outbreak in Tuscany, Italy: a genotypic and phenotypic characterisation 161
Variable performance of different commercial systems for testing carbapenem susceptibility of KPC carbapenemase-producing Escherichia coli 160
Discrepancies in fosfomycin susceptibility testing of KPC-producing Klebsiella pneumoniae with various commercial methods 159
Draft genome sequence of Proteus mirabilis NO-051/ 03, representative of a multidrug-resistant clone spreading in Europe and expressing the CMY-16 AmpC-type β-lactamase 157
Cross-infection of solid organ transplant recipients by a multidrug-resistant Klebsiella pneumoniae isolate producing the OXA-48 carbapenemase, likely derived from a multiorgan donor 157
Evaluation of the commercial AD fosfomycin test for susceptibility testing of multidrug-resistant Enterobacterales and Pseudomonas aeruginosa 156
Assessment of the Phoenix™ automated system and EUCAST breakpoints for antimicrobial susceptibility testing against isolates expressing clinically relevant resistance mechanisms 155
Up-regulation of resident chromosomal fosB gene expression: a novel mechanism of acquired fosfomycin resistance in MRSA 152
Carbapenemase-producing Enterobacteriaceae during 2011-12 in the Bolzano area (Northern Italy): Increasing diversity in a low-endemicity setting 152
Impact of a clinical microbiology-intensive care consulting program in a cardiothoracic intensive care unit 152
Diagnostic stewardship for sepsis: The need for risk stratification to triage patients for fast microbiology workflows 151
Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosa isolates in a university hospital in central Italy 150
Widespread emergence of OmpK36 loop 3 insertions among multidrug-resistant clones of Klebsiella pneumoniae 147
Evaluation of Quantamatrix dRASTTM system for rapid antimicrobial susceptibility testing of bacterial isolates from positive blood cultures, in comparison with commercial Micronaut broth microdilution system 145
Effectiveness of a Multifaced Antibiotic Stewardship Program: A Pre-Post Study in Seven Italian ICUs 145
In vivo evolution to Colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment 145
Evaluation of the OXA-23 K-SeT ® immunochromatographic assay for the rapid detection of OXA-23-like carbapenemase- producing Acinetobacter spp. 143
Identification of a novel plasmid lineage associated with the dissemination of metallo-β-lactamase genes among pseudomonads 143
The changing epidemiology of carbapenemase-producing Klebsiella pneumoniae in Italy: toward polyclonal evolution with emergence of high-risk lineages 143
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 140
Evaluation of the Liquid Colony™ Produced by the FAST System for Shortening the Time of Bacterial Identification and Phenotypic Antimicrobial Susceptibility Testing and Detection of Resistance Mechanisms from Positive Blood Cultures 140
KPC-31 expressed in a ceftazidime/avibactam-resistant Klebsiella pneumoniae is associated with relevant detection issues 140
Methicillin-resistant Staphylococcus aureus (MRSA) in hospitalized patients from the Bolivian Chaco. 140
Activity of fosfomycin/colistin combinations against planktonic and biofilm Gram-negative pathogens 139
In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator 139
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread 137
Evaluation of three commercial lateral flow immunoassays for the detection of KPC, VIM, NDM, IMP and OXA-48-like carbapenemases 135
Hypervirulent Klebsiella pneumoniae Strains Modulate Human Dendritic Cell Functions and Affect TH1/TH17 Response 135
Evaluation of RESIST ACINETO immunochromatographic assay from positive blood cultures 131
Direct identification of microorganisms from positive blood cultures using the lysis-filtration technique and matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS): a multicentre study 130
VIM-1-producing Pseudomonas mosselii isolates in Italy, predating known VIM-producing index strains 128
Performance evaluation of the UMIC® Cefiderocol to determine MIC in Gram-negative bacteria 127
Next-generation diagnostics of bloodstream infections enabled by rapid whole-genome sequencing of bacterial cells purified from blood cultures 126
Inhibitory activity of avibactam against selected β-lactamases expressed in an isogenic Escherichia coli strain 126
Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates 125
Characterization of Extensively Drug-Resistant or Pandrug-Resistant Sequence Type 147 and 101 OXA-48-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Patients in an Intensive Care Unit 124
In vivo evolution to high-level cefiderocol resistance of NDM-1-producing Klebsiella pneumoniae, followed by intra-hospital cross-transmission 122
Intussusceptive angiogenesis in Covid-19: hypothesis on the significance and focus on the possible role of FGF2 122
Update on activity of dalbavancin and comparators against clinical isolates of Gram-positive pathogens from Europe and Russia (2017–2018), and on clonal distribution of MRSA 122
Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications 121
In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates 118
Results of the Italian infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-IT): Activity of ceftazidime/avibactam against Enterobacterales isolated from urine 118
Evaluation of two commercial broth microdilution systems for dalbavancin susceptibility testing of methicillin-resistant Staphylococcus aureus and other resistant Gram-positive cocci 117
Escherichia coli from Italy producing OXA-48 carbapenemase encoded by a novel Tn1999 transposon derivative 117
Acquired AmpC type beta-lactamases: an emerging problem in Italian long-term care and rehabilitation facilities 117
Treatment and diagnosis of severe KPC-producing Klebsiella pneumoniae infections: a perspective on what has changed over last decades 116
A simple phenotypic method for screening of MCR-1-mediated colistin resistance 116
Rapid detection of intestinal carriage of Klebsiella pneumoniae producing KPC carbapenemase during an outbreak 115
Large oligoclonal outbreak due to klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit 115
KPC-53, a KPC-3 variant of clinical origin associated with reduced susceptibility to ceftazidime-avibactam 115
Ceftazidime-avibactam resistance associated with increased blaKPC-3 gene copy number mediated by pKpQIL plasmid derivatives in sequence type 258 Klebsiella pneumoniae 114
Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam 112
Chloramphenicol activity against carbapenemase producing Enterobacterales 107
Synergistic activity of colistin plus rifampin against colistin-resistant kpc-producing klebsiella pneumoniae 106
Rapid resistome fingerprinting and clonal lineage profiling of carbapenem-resistant Klebsiella pneumoniae isolates by targeted next-generation sequencing 105
Treatment of severe infections due to metallo-β-lactamases-producing Gram-negative bacteria 104
Direct identification of bacteria in blood culture by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: a new methodological approach 101
Totale 17.224
Categoria #
all - tutte 50.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.082


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021133 0 0 0 0 0 0 0 0 0 0 57 76
2021/2022626 18 25 63 19 26 31 42 55 35 40 65 207
2022/20231.513 174 355 72 106 67 265 190 62 150 20 29 23
2023/2024774 29 81 119 31 53 75 41 152 26 74 33 60
2024/20255.274 197 519 321 828 1.400 673 159 367 221 158 199 232
2025/20265.350 597 916 580 660 600 231 525 312 368 310 251 0
Totale 18.460